In real-world clinical practice current status of refractory with topical antifungal drug therapy on onychomycosis and efficacy and safety of fosravuconazole switching treatment: a retrospective study
Not Applicable
Recruiting
- Conditions
- Onychomycosis
- Registration Number
- JPRN-UMIN000048054
- Lead Sponsor
- Sato Pharmaceutical Co., Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with significant thickening, deformation, or discoloration of the nails due to diseases such as palmoplantar pustulosis psoriasis vulgaris, lichen planus, pachyonychia , subungual tumor, or onychogryphosis 2) Patients who refuse to provide medical information for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method